Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Solution Group Bhd managing director Barry Lim points to the thousands of workers in the private sector, especially foreign workers, who are in urgent need of vaccination.
“I don’t think they can wait for the government supply. We are also actively engaging partners in the Asean countries.”
It is worth noting that Solution received the National Pharmaceutical Regulatory Agency’s (NPRA) approval last Thursday for the design plan and layout of its vaccine fill and finish facility. This means the company can begin construction of the facility, which is expected to be ready by March next year.
The expansion will be funded by its recent private placement to raise RM18.67 million. An extraordinary general meeting will be held at the end of this month for its proposed diversification into the pharmaceutical-related business.
Among companies venturing into vaccine distribution, Solution has been the best performer in terms of share price performance since announcing its venture in August.
